DXCM
DEXCOM INC
Key Financials
Operating Income
$911.8M
↑ 52.0%
Net Income
$836.3M
↑ 45.1%
Gross Profit
$2.8B
↑ 14.9%
Revenue
$4.7B
↑ 15.6%
EPS (Diluted)
$2.09
↑ 47.2%
Total Assets
$6.3B
↓ 2.2%
Total Liabilities
$3.6B
↓ 18.0%
Shareholders' Equity
$2.7B
↑ 30.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 4/16/2026 | View on SEC |
| ARS | 4/15/2026 | View on SEC |
| DEFA14A | 4/15/2026 | View on SEC |
| DEF 14A | 4/15/2026 | View on SEC |
| 144 | 4/15/2026 | View on SEC |
| SCHEDULE 13G/A | 3/26/2026 | View on SEC |
| 4 | 3/18/2026 | View on SEC |
| 144 | 3/16/2026 | View on SEC |
| 4 | 3/10/2026 | View on SEC |
| 4 | 3/10/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | DXCM |
| Company Name | DEXCOM INC |
| CIK | 1093557 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 8582000200 |